Cell and gene therapy is experiencing significant trends and growth, with the market expected to expand substantially by the mid-2030s. The size of the market is projected to reach tens of billions of dollars, with estimates ranging from around $45 billion to over $125 billion by 2034 or 2035. Various factors, including advances in delivery technologies and clinical trials, are driving progress and shaping the future of cell and gene therapy.